InChI=1S/C24H28N2O5/c1- 2- 31- 24(30) 20(14- 12- 17- 8- 4- 3- 5- 9- 17) 25- 19- 15- 13- 18- 10- 6- 7- 11- 21(18) 26(23(19) 29) 16- 22(27) 28/h3- 11,19- 20,25H,2,12- 16H2,1H3,(H,27,28) /t19- ,20- /m0/s1 |
XPCFTKFZXHTYIP-PMACEKPBSA-N |
CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(O)=O)C1=O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
An EC 3.4.15.* (peptidyl-dipeptidase) inhibitor that interferes with the action of peptidyl-dipeptidase A (EC 3.4.15.1).
|
|
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
An EC 3.4.15.* (peptidyl-dipeptidase) inhibitor that interferes with the action of peptidyl-dipeptidase A (EC 3.4.15.1).
prodrug
A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
|
|
View more via ChEBI Ontology
[(3S)- 3- {[(1S)- 1- (ethoxycarbonyl)- 3- phenylpropyl]amino}- 2- oxo- 2,3,4,5- tetrahydro- 1H- 1- benzazepin- 1- yl]acetic acid
|
bénazépril
|
WHO MedNet
|
benazepril
|
WHO MedNet
|
benazepril
|
WHO MedNet
|
benazeprilum
|
WHO MedNet
|
1H- 1- Benzazepine- 1- acetic acid, 3- ((1- (ethoxycarbonyl)- 3- phenylpropyl)amino)- 2,3,4,5- tetrahydro- 2- oxo- , (S- (R*,R*))-
|
ChemIDplus
|
Benazepril
|
KEGG COMPOUND
|
4302258
|
Reaxys Registry Number
|
Reaxys
|
86541-75-5
|
CAS Registry Number
|
ChemIDplus
|
25224804
|
PubMed citation
|
Europe PMC
|
25738503
|
PubMed citation
|
Europe PMC
|
25784709
|
PubMed citation
|
Europe PMC
|
25912588
|
PubMed citation
|
Europe PMC
|
|